
Globally, more than 25% of all incident cases of tuberculosis (TB) occur in India, which is more TB cases than in any other country in the world. In excess of 2.6 million new cases of TB and approximately 500,000 TB-related deaths occurred in India in 2020. Although India has made strides in TB control, progress has been incremental, and acceleration of progress has been limited in part by systemic delays in diagnosis and initiation of TB therapy. It has long been appreciated that early TB diagnosis and treatment in India are hampered by the vast and unregulated private healthcare sector (2–4). The scale of this sector cannot be overstated, as nearly half of patients with TB in India may initially seek care from private practitioners...
Like
Save
Share